M Mordarski

1.6k citations
87 papers · 1.2k indexed · h-index 17
Topics
Actinomycetales infections and treatment (16 papers)Antimicrobial Resistance in Staphylococcus (13 papers)Microbial Natural Products and Biosynthesis (11 papers)

In The Last Decade

M Mordarski

79 papers receiving 1.1k citations

Peers

M Mordarski
Comparison fields: 5 of 92
  • Molecular Biology 660
  • Microbiology 257
  • Plant Science 241
  • Pharmacology 236
  • Organic Chemistry 211
Replace Benjamin Becker with:
Benjamin Becker United States
Jolanta Zakrzewska‐Czerwińska Poland
Katsukiyo Yazawa Japan
Lawrence G. Wayne United States
Fuminori Kanetsuna Venezuela
M. A. Lanéelle France
Azusa Takahashi‐Nakaguchi Japan
Helen M. Kieser United Kingdom
Hédia Marrakchi France
David J. Haydon United Kingdom
M Mordarski relative to Benjamin Becker United States Benjamin Becker's profile →
Citations per field
00.5×
Benjamin Becker · 1×
Citations per year

Countries citing papers authored by M Mordarski

Since Specialization
Citations

This map shows the geographic impact of M Mordarski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mordarski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mordarski more than expected).

Fields of papers citing papers by M Mordarski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Mordarski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mordarski. The network helps show where M Mordarski may publish in the future.

Co-authorship network of co-authors of M Mordarski

This figure shows the co-authorship network connecting the top 25 collaborators of M Mordarski. A scholar is included among the top collaborators of M Mordarski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Mordarski. M Mordarski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 8
3 18
4 4
5 29
6 24
7 3
8 4
9 32
10 9
11 0
12
Antineoplastic activity of new linear hydrazine derivatives.
4
13
Biological activity of 1,4-dihydropyridine derivatives.
4
14
The Biology of the actinomycetes
274
15
Chemical, pharmacological and oncostatic properties of 5-(4'-hydroxybenzylidenoimino)-4, 6-diketo-4, 5, 6, 7-tetrahydropyrimidine-[4, 5-d]-3-methyl-isothiazole (compound IP-10).
1
16 13
17
Nocardia and streptomyces. Proceedings of the International Symposium on Nocardia and Streptomyces, Warsaw, October 4-8, 1976.
1
18 3
19 6
20
Antibiotics produced by Streptomyces olivaceus 142. I. Characterization of the FPG mutant and conditions of production of antibiotic WR 142-FPG.
3

About M Mordarski

M Mordarski is a scholar working on Microbiology, Biotechnology and Small Animals, having authored 87 papers that have together received 1.2k indexed citations. Recurring topics across this work include Actinomycetales infections and treatment (16 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Microbial Natural Products and Biosynthesis (11 papers). The work is most often cited by research in Microbiology (257 citations), Pharmacology (236 citations) and Biotechnology (115 citations). M Mordarski has collaborated with scholars based in Poland, Germany and United Kingdom. Frequent co-authors include Michael Goodfellow, Stanley T. Williams, G. Pulverer, H Mordarska, Jolanta Zakrzewska‐Czerwińska, K. Szyba, W Peczyńska-Czoch, Łukasz Kaczmarek, Andrzej Tkacz and K. P. Schaal. Their work appears in journals such as Nature, Gene and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026